RT Journal Article
SR Electronic
T1 Information Theoretic Model Selection for Accurately Estimating Unreported COVID-19 Infections
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.14.21263467
DO 10.1101/2021.09.14.21263467
A1 Cui, Jiaming
A1 Haddadan, Arash
A1 Haque, A S M Ahsan-Ul
A1 Adhikari, Bijaya
A1 Vullikanti, Anil
A1 Prakash, B. Aditya
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.14.21263467.abstract
AB Estimating the true extent of the outbreak was one of the major challenges in combating COVID-19 outbreak early on. Our inability in doing so, allowed unreported/undetected infections to drive up disease spread in numerous regions in the US and worldwide. Accurately identifying the true magnitude of infections still remains a major challenge, despite the use of surveillance-based methods such as serological studies, due to their costs and biases. In this paper, we propose an information theoretic approach to accurately estimate the unreported infections. Our approach, built on top of an existing ordinary differential equations based epidemiological model, aims to deduce an optimal parameterization of the epidemiological model and the true extent of the outbreak which “best describes” the observed reported infections. Our experiments show that the parameterization learned by our framework leads to a better estimation of unreported infections as well as more accurate forecasts of the reported infections compared to the baseline parameterization. We also demonstrate that our framework can be leveraged to simulate what-if scenarios with non-pharmaceutical interventions. Our results also support earlier findings that a large majority of COVID-19 infections were unreported and non-pharmaceutical interventions indeed helped in mitigating the COVID-19 outbreak.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis paper was partially supported by the NSF (Expeditions CCF-1918770 and CCF-1918656, CA- REER IIS-2028586, RAPID IIS-2027862, Medium IIS-1955883, Medium IIS-2106961, IIS-1931628, IIS-1955797, IIS-2027848), NIH 2R01GM109718, CDC MInD program U01CK000589, ORNL and funds/computing resources from Georgia Tech and GTRI. B. A. was in part supported by the CDC MInD-Healthcare U01CK000531-Supplement. A.V.'s work is also supported in part by grants from the UVA Global Infectious Diseases Institute (GIDI).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical problems included.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCoronavirus in the U.S.:Latest Map and Case Count, 2020. URL https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html. Eran Bendavid, Bianca Mulaney, Neeraj Sood, Soleil Shah, Rebecca Bromley-Dulfano, Cara Lai, Zoe Weissberg, Rodrigo Saavedra-Walker, Jim Tedrow, Andrew Bogan, et al. Covid-19 antibody seroprevalence in santa clara county, california. International journal of epidemiology, 50(2):410-419, 2021. Fiona P Havers, Carrie Reed, Travis Lim, Joel M Montgomery, John D Klena, Aron J Hall, Alicia M Fry, Deborah L Cannon, Cheng-Feng Chiang, Aridth Gibbons, et al. Seroprevalence of antibodies to sars-cov-2 in 10 sites in the united states, march 23-may 12, 2020. JAMA internal medicine, 180(12):1576-1586, 2020. Delphi's COVID-19 Surveys, 2020. URL https://delphi.cmu.edu/covidcast/surveys/. https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html https://delphi.cmu.edu/covidcast/surveys/